Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score.

[1]  Yoon-Koo Kang,et al.  Prognostic Scoring Models for Patients Undergoing Sorafenib Treatment for Advanced Stage Hepatocellular Carcinoma in Real-Life Practice , 2017, American journal of clinical oncology.

[2]  Masatoshi Kudo,et al.  Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial , 2017, The Lancet.

[3]  T. Meyer,et al.  A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[4]  Chia-Yang Hsu,et al.  Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. , 2016, Journal of hepatology.

[5]  J. Blanc,et al.  Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C results from a French multicenter study , 2015, European journal of gastroenterology & hepatology.

[6]  N. Izumi,et al.  Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinoma , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  J. Raoul,et al.  Retreatment with TACE: the ABCR SCORE, an aid to the decision-making process. , 2015, Journal of hepatology.

[8]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[9]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Chia-Yang Hsu,et al.  Aggressive Therapeutic Strategies Improve the Survival of Hepatocellular Carcinoma Patients with Performance Status 1 or 2: A Propensity Score Analysis , 2015, Annals of Surgical Oncology.

[11]  H. Heinzl,et al.  How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma. , 2014, Journal of hepatology.

[12]  S. Fan,et al.  Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. , 2014, Gastroenterology.

[13]  H. Heinzl,et al.  The ART-strategy: sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE. , 2014, Journal of hepatology.

[14]  A. Burroughs,et al.  A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  D. Semela,et al.  Sorafenib: from literature to clinical practice. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Chia-Yang Hsu,et al.  Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system , 2013, Hepatology.

[17]  V. Mazzaferro,et al.  Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions , 2012, Seminars in Liver Disease.

[18]  C. Verslype,et al.  Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  Easl.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma , 2012 .

[20]  J. Marrero,et al.  Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort , 2005, Hepatology.

[21]  S. Chevret,et al.  A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. , 1999, Journal of hepatology.

[22]  F. Izzo,et al.  A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients , 1998, Hepatology.

[23]  N. Okazaki,et al.  Prognosis of Primary Hepatocellular Carcinoma , 1984, Hepatology.